Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Angle Plc LSE:AGL London Ordinary Share GB0034330679 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -0.94% 52.50 51.00 54.00 53.00 52.00 53.00 225,728 12:50:36
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.0 -17.4 -6.7 - 137

Angle Share Discussion Threads

Showing 22801 to 22820 of 24975 messages
Chat Pages: Latest  915  914  913  912  911  910  909  908  907  906  905  904  Older
DateSubjectAuthorDiscuss
29/9/2022
10:41
Cost of solid biopsy for metastatic site (which is already in the cancer guidelines) e.g. of liver or lung is $16,000. So health economics for using Parsortix is very strong.
sicilian_kan
29/9/2022
10:38
Without doubt, whether a masterstroke or a fluke, when you consider the backdrop od rates and funding issues, and any AIM stocks that require funding are currently being obliterated .. the placing was soooo important to get out the way ASAP.

"Shortly after the period end, ANGLE successfully completed a fundraising of GBP20.1 million (GBP18.9 million net of expenses). Recognizing the current adverse market conditions and wider macroeconomic environment"

onedayrodders
29/9/2022
10:28
One of thems abbot....T trolley this morning in London
amaretto1
29/9/2022
10:27
Got kicked out on PC but working on mobile
sicilian_kan
29/9/2022
10:25
If he had not been so unpleasant we could do a quick whip round for a cup of tea
pattsaloser
29/9/2022
10:24
On the plus side it may shut his lies up for a few days ...

extra ambulance duties for the convict

(aka uber driver from brixton bedsit)

pattsaloser
29/9/2022
10:23
H75 looks like the convicts losses are mounting ENET round with the begging bowl classic pump and dump crooked Israel based tech companies lesson one on AIM avoid tech companies out of Israel even if they appear amazing...
pattsaloser
29/9/2022
10:22
Using Pap staining via Parsortix as a Trojan Horse to get Parsortix into the labs because clinicians / technicians (?) are already well used to doing this
sicilian_kan
29/9/2022
10:14
Has your end frozen?
tightfist
29/9/2022
10:14
Webcast underway:

AN said something along lines of particularly pleased with large medtech companies where there is an increased sense of urgency to work with us.

Talked about PDL1 customer also doing DNA damage repair assay, successfully completed assay development phase meeting their requirement. The customer will then have to use it in their trials - they don't have an alternative.

Of the 20 customers in discussion with, they include 3x household name pharma companies

sicilian_kan
29/9/2022
09:51
What with 40 million in the bank .....Try harder Toffee Apple !
amaretto1
29/9/2022
09:42
>>amaretto1

Will a new brake do instead of a wheel? see SCE

toffeeman
29/9/2022
09:17
Spandex have got their shorts on ENET!
1liam
29/9/2022
08:25
What was Grails revenues before illumina paid them 7 billion ?
amaretto1
29/9/2022
08:23
Absolute rubbish..We have a hedge fund suppressing the share price Nothing to do with current earnings.This technology is in a 100 billion liquid biopsy mkt ...We are the most advanced of them all.If you invented a New form of wheel .. what valuation would a car manufacturer put on that ?
amaretto1
29/9/2022
08:14
Dibs61. Slightly disagree. The market is terrified of lack of cashflow. Once traction on revenue is gained then rapid rise. I don’t think it is games.
purchaseatthetop
29/9/2022
08:08
No need. I asked your boyfriend Amaretto, he knows all about going down.
1liam
29/9/2022
08:02
Convict,
How are your 200K losses doing?

🤣

halland75
29/9/2022
07:57
All kinds of shenanigans going on here lol. No one can convince me this is normal market behaviour/reaction to what is truly a STELLAR RNS. There’s a hedge fund at work here suppressing the price artificially. No way this company will still be independent in 12 months time. They have industry disrupting technology in multi hundred BILLION dollar market. Market leading position with all the proof you need that the product works.

Abbot are on the acquisition trail. I am now 100% convinced we will see a buy out here. Could be before the end of this year. Abbot will not sit on their hands much longer.

This is a sitting duck at this utterly absurd market valuation. The only question is what will the buy out price be? Much more than 65p that’s for sure!

dibs61
29/9/2022
07:55
It’s my pointless clone again.
purchaseatthetop
Chat Pages: Latest  915  914  913  912  911  910  909  908  907  906  905  904  Older
Your Recent History
LSE
AGL
Angle
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221208 03:59:15